<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2606245441
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2019
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        AZACITIDINE SPC 100 MG INJECTION
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        AZACITIDINE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        100
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous, Subcutaneous
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Powder for suspension for injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Vial
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        1157.4
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Dr. Reddy&#x2019;s Laboratories Ltd. Formulation Unit VII" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Dr. Reddy’s Laboratories Ltd. Formulation Unit VII
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 2272]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SUDAIR PHARMA COMPANY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            SUDAIR PHARMA COMPANY
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        L01BC07 
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What Azacitidine SPC is</strong></p><p>Azacitidine SPC is an anti-cancer agent which belongs to a group of medicines called &lsquo;anti- metabolites&rsquo;. Azacitidine SPC contains the active substance &lsquo;azacitidine&rsquo;.</p><p><strong>What Azacitidine SPC is used for</strong></p><p>Azacitidine SPC is used in adults who are not able to have a stem cell transplantation to treat:</p><p>&bull;&nbsp; higher-risk myelodysplastic syndromes (MDS).</p><p>&bull;&nbsp; chronic myelomonocytic leukaemia (CMML).</p><p>&bull;&nbsp; acute myeloid leukaemia (AML).</p><p>These are diseases which affect the bone marrow and can cause problems with normal blood cell production.</p><p><strong>How Azacitidine SPC works</strong></p><p>Azacitidine SPC works by preventing cancer cells from growing. Azacitidine becomes incorporated into the genetic material of cells (ribonucleic acid (RNA) and deoxyribonucleic acid (DNA)). It is thought to work by altering the way the cell turns genes on and off and also by interfering with the production of new RNA and DNA. These actions are thought to correct problems with the maturation and growth of young blood cells in the bone marrow that cause myelodysplastic disorders, and to kill cancerous cells in leukaemia.</p><p>Talk to your doctor or nurse if you have any questions about how Azacitidine SPC works or why this medicine has been prescribed for you.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not use Azacitidine SPC</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are allergic to azacitidine or any of the other ingredients of this medicine (listed in section 6).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have advanced liver cancer.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are breast-feeding.</p><p><strong>Warnings and precautions</strong></p><p>Talk to your doctor, pharmacist or nurse before using Azacitidine SPC:</p><p>&bull;&nbsp; if you have decreased counts of platelets, red or white blood cells.</p><p>&bull;&nbsp; if you have kidney disease.</p><p>&bull;&nbsp; if you have liver disease.</p><p>&bull;&nbsp; if you have ever had a heart condition or heart attack or any history of lung disease. <u>Blood test</u></p><p>You will have blood tests before you begin treatment with Azacitidine SPC and at the start of each period of treatment (called a &lsquo;cycle&rsquo;). This is to check that you have enough blood cells and that your liver and kidneys are working properly.</p><p><strong>Children and adolescents</strong></p><p>Azacitidine SPC is not recommended for use in children and adolescents below the age of 18.</p><p><strong>Other medicines and Azacitidine SPC</strong></p><p>Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines. This is because Azacitidine SPC may affect the way some other medicines work. Also, some other medicines may affect the way Azacitidine SPC works.</p><p><strong>Pregnancy, breast-feeding and fertility</strong></p><p><u>Pregnancy</u></p><p>You should not use Azacitidine SPC during pregnancy as it may be harmful to the baby. Use an effective method of contraception during and up to 3 months after treatment.</p><p>Tell your doctor straight away if you become pregnant during treatment.</p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.</p><p><u>Breast-feeding</u></p><p>You should not breast-feed when using Azacitidine SPC. It is not known if this medicine passes into human milk.</p><p><u>Fertility</u></p><p>Men should not father a child while receiving treatment with Azacitidine SPC. Use an effective method of contraception during and up to 3 months after treatment with this medicine.</p><p>Talk to your doctor if you wish to conserve your sperm before starting this treatment.</p><p><strong>Driving and using machines</strong></p><p>Do not drive or use any tools or machines if you experience side effects, such as tiredness.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Before giving you Azacitidine SPC, your doctor will give you another medicine to prevent nausea and vomiting.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The recommended dose is 75 mg per m2 body surface area. Your doctor will decide your dose of this medicine, depending on your general condition, height and weight. Your doctor will check your progress and may change your dose if necessary.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Azacitidine SPC is given every day for one week, followed by a rest period of 3 weeks. This &ldquo;treatment cycle&rdquo; will be repeated every 4 weeks. You will usually receive at least 6 treatment cycles.</p><p>This medicine will be given to you as an injection under the skin (subcutaneously) by a doctor or nurse. It may be given under the skin on your thigh, tummy or upper arm.</p><p>If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>&nbsp;</p><p>Tell your doctor straight away if you notice any of the following side effects:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Drowsiness, shaking, jaundice, abdominal bloating and easy bruising</strong>. These may be symptoms of liver failure and can be life-threatening.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Swelling of the legs and feet, back pain, reduced passing of water, increased thirst, rapid pulse, dizziness and nausea, vomiting or reduced appetite and feelings of confusion, restlessness or fatigue. </strong>These may be symptoms of kidney failure and can be life-threatening.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>A fever</strong>. This could be due to an infection as a result of having low levels of white blood cells, which can be life-threatening.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Chest pain or shortness of breath which may be accompanied with a fever. </strong>This may be dueto an infection of the lung called &ldquo;pneumonia&rdquo;, and can be life-threatening.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Bleeding. </strong>Such as blood in the stools due to bleeding in the stomach or gut, or such as bleeding inside your head. These may be symptoms of having low levels of platelets in your blood.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Difficulty breathing, swelling of the lips, itching or rash. </strong>This may be due to an allergic (hypersensitivity) reaction.</p><p>&nbsp;</p><p>Other side effects include:</p><p>&nbsp;</p><p><strong>Very common side effects </strong>(may affect more than 1 in 10 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reduced red blood count (anaemia). You may feel tired and pale.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reduced white blood cell count. This may be accompanied by a fever. You are also more likelyto get infections.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A low blood platelet count (thrombocytopenia). You are more prone to bleeding and bruising.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Constipation, diarrhoea, nausea, vomiting.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pneumonia.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chest pain, being short of breath.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tiredness (fatigue).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Injection site reaction including redness, pain or a skin reaction.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Loss of appetite.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Joint aches.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bruising.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rash.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Red or purple spots under your skin.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pain in your belly (abdominal pain).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Itching.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fever.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sore nose and throat.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dizziness.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Headache.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Having trouble sleeping (insomnia).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nosebleeds (epistaxis).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Muscle aches.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Weakness (asthenia).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Weight loss.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Low levels of potassium in your blood.</p><p>&nbsp;</p><p><strong>Common side effects </strong>(may affect up to 1 in 10 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bleeding inside your head.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; An infection of the blood caused by bacteria (sepsis). This may be due to low levels of white cells in your blood.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bone marrow failure. This can cause low levels of red and white blood cells and platelets.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A type of anaemia where your red and white blood cells and platelets are reduced.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; An infection in your urine.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A viral infection causing cold sores (herpes).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bleeding gums, bleeding in the stomach or gut, bleeding from around your back passage due to piles (haemorrhoidal haemorrhage), bleeding in your eye, bleeding under your skin, or into your skin (haematoma).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Blood in your urine.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ulcers of your mouth or tongue.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes to your skin at the injection site. These include swelling, a hard lump, bruising, bleeding into your skin (haematoma), rash, itching and changes in the skin colour.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Redness of your skin.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Skin infection (cellulitis).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; An infection of the nose and throat, or sore throat.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sore or runny nose or sinuses (sinusitis).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; High or low blood pressure (hypertension or hypotension).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Being short of breath when you move.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pain in your throat and voicebox.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Indigestion.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lethargy.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Feeling generally unwell.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Anxiety.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Being confused.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hair loss.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Kidney failure.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dehydration.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; White coating covering tongue, inner cheeks, and sometimes on the roof of your mouth, gums and tonsils (oral fungal infection).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fainting.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A fall in blood pressure when standing (orthostatic hypotension) leading to dizziness when moving to a standing or sitting position.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sleepiness, drowsiness (somnolence).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bleeding due to a catheter line.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A disease affecting the gut which can result in fever, vomiting and stomach pain (diverticulitis).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fluid around the lungs (pleural effusion).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Shivering (chills).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Muscle spasms.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Raised itchy rash on the skin (urticaria).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Collection of fluid around the heart (pericardial effusion).</p><p>&nbsp;</p><p><strong>Uncommon side effects </strong>(may affect up to 1 in 100 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Allergic (hypersensitivity) reaction.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Shaking.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Liver failure.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Large plum-coloured, raised painful patches on the skin with fever.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Painful skin ulceration (pyoderma gangrenosum). Inflammation of the lining around the heart (pericarditis).</p><p>&nbsp;</p><p><strong>Rare side effects </strong>(may affect up to 1 in 1,000 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dry cough.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Painless swelling in the finger tips (clubbing).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tumour lysis syndrome - Metabolic complications that can occur during treatment of cancer and sometimes even without treatment. These complications are caused by the product of dying cancer cells and may include the following: changes to blood chemistry; high potassium, phosphorus, uric acid, and low calcium consequently leading to changes in kidney function, heartbeat, seizures, and sometimes death.</p><p>&nbsp;</p><p><strong>Not known (</strong>frequency cannot be estimated from the available data)</p><p>Infection of the deeper layers of skin, which spreads quickly, damaging the skin and tissue, which canbe life-threatening (necrotizing fasciitis).</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>Reporting of side effects</strong></p><p><strong>&nbsp;</strong></p><p>If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your &lt;doctor, health care provider&gt; &lt;or&gt; &lt;pharmacist&gt;.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>&nbsp;</p><p>Do not use this medicine after the expiry date which is stated on the vial label and the carton. The expiry date refers to the last day of that month.</p><p>Your doctor, pharmacist or nurse are responsible for storing AZACITIDINE SPC. They are also responsible for preparing and disposing of any unused AZACITIDINE SPC correctly.</p><p>&nbsp;</p><p>For unopened vials of this medicine &ndash; there are no special storage conditions.</p><p>&nbsp;</p><p><em>When using immediately</em></p><p><em>&nbsp;</em></p><p>Once the suspension has been prepared it should be administered within 45 minutes.</p><p>&nbsp;</p><p><em>When using later on</em></p><p><em>&nbsp;</em></p><p>If the AZACITIDINE SPC suspension is prepared using water for injections that has not been refrigerated, the</p><p>&nbsp;</p><p>suspension must be placed in the refrigerator (2 &deg;C &ndash; 8 &deg;C) immediately after it is prepared and kept refrigerated for up to a maximum of 8 hours.</p><p>If the AZACITIDINE SPC suspension is prepared using water for injections that has been stored in the refrigerator</p><p>&nbsp;</p><p>(2 &deg;C &ndash; 8 &deg;C), the suspension must be placed in the refrigerator (2 &deg;C &ndash; 8 &deg;C) immediately after it is prepared and kept refrigerated for up to a maximum of 22 hours.</p><p>&nbsp;</p><p>&nbsp;</p><p>The suspension should be allowed up to 30 minutes prior to administration to reach room temperature (20 &deg;C &ndash; 25 &deg;C).</p><p>If large particles are present in the suspension it should be discarded.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The Active substance is <strong>Azacitidine.</strong></p><p>The other ingredients are Mannitol, Nitrogen and water for injection.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Azacitidine SPC for Injection 100 mg/vial is a white to off white lyophilised powder in Type I glass vial with rubber stopper containing 100 mg of Azacitidine.
Pack of 1 vial

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>MARKETING AUTHORIZATION HOLDER:</strong></p><p>Sudair Pharma Company (SPC)</p><p>King Fahad Road, Riyadh Gallery - Building A1, Riyadh, Saudi Arabia</p><p>Tel: +966-11-920001432</p><p>Fax: +966-11-4668195</p><p>Email: info@sudairpharma.com</p><p>Mailing: P.O. Box 12363 Riyadh, Saudi Arabia</p><p>&nbsp;</p><p><strong>Manufacturer</strong>:</p><p>Dr. Reddy&rsquo;s Laboratories Ltd. Formulation Unit VII</p><p>Plot No. P1 to P9, Phase III,</p><p>Duvvada, VSEZ, Visakhapatnam,</p><p>Andhra Pradesh, INDIA - 530 046</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in 10/2021
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL"><strong>ما دواء أزاسيتيدين اس بي سي</strong>؟</p><p dir="RTL">أزاسيتيدين اس بي سي عبارة عن عامل مضاد للأورام ينتمي إلى مجموعة أدوية يُطلق عليها اسم &quot;مضادات الأيض&quot;. يحتوي أزاسيتيدين اس بي سي على مادة أزاسيتيدين الفعالة.</p><p>&nbsp;</p><p>ما دواعي استعمال أزاسيتيدين اس بي سي؟</p><p dir="RTL">يُستعمل أزاسيتيدين اس بي سي في المرضىى البالغين الذين لا يمكنهم زرع خلايا جذعية لعلاج:</p><p dir="RTL">&bull; متلازمات خلل التنسج النقوي (MDS&rlm;) عالية الخطورة.</p><p dir="RTL">&bull; ابيضاض الدم الوحيدي النقوي المزمن (&rlm;CMML&rlm;).</p><p dir="RTL">&bull; ابيضاض الدم النقوي الحاد (&rlm;AML&rlm;).</p><p dir="RTL">هذه الأمراض من شأنها أن تؤثر في نخاع العظم وتتسبب في مشكلات في تخليق خلايا الدم الطبيعية.</p><p>&nbsp;</p><p>طريقة عمل أزاسيتيدين اس بي سي</p><p>يعمل أزاسيتيدين اس بي سي عن طريق منع نمو الخلايا السرطانية. حيث يتداخل أزاسيتيدين مع المادة الوارثية بالخلايا (الحمض النووي الريبوزي والحمض النووي الريبوزي منزوع الأكسجين). يُعتقد أنه يعمل عبر تغيير طريقة تفعيل او ايقاف الخلية للجينات، وكذلك عبر التداخل مع عملية تصنيع الحمض النووي الريبيوزىي والحمض النووي الريبيوزي منزوع الأكسجين الجديد. ويُعتقد أن هذا المفعول يصحح مشكلات نضج ونمو خلايا الدم الحديثة في نخاع العظم، والتي تسبب اضطرابات خلل التنسج النقوي، بالإضافة إلى قتل الخلايا السرطانية في ابيضاض الدم.</p><p dir="RTL">تحدث إلى طبيبك أو&nbsp;الممرض إذا كانت لديك أي أسئلة عن طريقة عمل أزاسيتيدين اس بي سي، أو&nbsp;سبب وصف هذا الدواء لك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>لا تستخدم أزاسيتيدين اس بي سي</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من حساسية تجاه أزاسيتيدين أو&nbsp;أي من المكونات الأخرى بهذا الدواء (مُدرجة في القسم 6).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من سرطان متقدم في الكبد.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنتِ ترضعين رضاعة طبيعية.</p><p>&nbsp;</p><p><strong>التحذيرات والاحتياطات</strong></p><p>تحدث مع طبيبك، أو&nbsp;الصيدلي، أو&nbsp;الممرض قبل استعمال أزاسيتيدين اس بي سي:</p><p>&bull; إذا كنت تعاني من انخفاض عدد الصفائح الدموية أو&nbsp;كريات الدم الحمراء أو&nbsp;البيضاء.</p><p>&bull; إذا كنت تعاني من مرض في الكلى.</p><p>&bull; إذا كنت تعاني من مرض في الكبد.</p><p>&bull; إذا عانيت سابقًا من حالة أو&nbsp;نوبة قلبية، أو&nbsp;كان لديك أي تاريخ مرضي لمرض من أمراض الرئة.</p><p><u>فحص الدم</u></p><p>ستجري لك فحوصات دم قبل بدء العلاج باستخدام أزاسيتيدين اس بي سي، وفي بداية كل فترة علاج (يُطلق عليها &quot;دورة علاجية&quot;). ويهدف ذلك الفحص إلى التحقق من وجود خلايا دم كافية، وأن الكبد والكلى يعملان على نحو صحيح.</p><p>&nbsp;</p><p><strong>الأطفال والمراهقون</strong></p><p>لا يُنصح باستعمال أزاسيتيدين اس بي سي لدى الأطفال والمراهقين الذين تقل أعمارهم عن 18 عامًا.</p><p>&nbsp;</p><p><strong>الأدوية الأخرى وأزاسيتيدين اس بي سي</strong></p><p>أخبر طبيبك أو&nbsp;الصيدلي إذا كنت تأخذ، أو&nbsp;أخذت مؤخرا، أو&nbsp;قد تأخذ أي أدوية أخرى، ذلك لأن أزاسيتيدين اس بي سي قد يؤثر في طريقة عمل بعض الأدوية الأخرى. كما يُمكن أن تؤثر بعض الأدوية الأخرى في طريقة عمل أزاسيتيدين اس بي سي.</p><p>&nbsp;</p><p>الحمل والرضاعة والخصوبة</p><p><u>الحمل</u></p><p>- يجب عدم استعمال أزاسيتيدين اس بي سي خلال فترة الحمل لأنه قد يضر بالجنين.</p><p>- يجب استخدام وسيلة فعالة لمنع الحمل خلال فترة العلاج وبعد العلاج لمدة تصل إلى 3 أشهر.</p><p>- أخبري الطبيب على الفور إذا أصبحتِ حاملًا في أثناء العلاج.</p><p>- يُرجى استشارة طبيبكِ أو&nbsp;الصيدلي قبل تناول هذا الدواء إذا كنتِ حاملًا أو&nbsp;مرضعًا، أو&nbsp;تعتقدين بأنك حامل أو&nbsp;تخططين لذلك.</p><p>&nbsp;</p><p><u>الرضاعة الطبيعية</u></p><p>يجب ألا ترضعي رضاعة طبيعية في أثناء تناول أزاسيتيدين اس بي سي. من غير المعروف ما إذا كان هذا الدواء يصل إلى لبن الأم أم لا.</p><p>&nbsp;</p><p><u>الخصوبة</u></p><p>- يجب على الذكور تجنب عملية الإنجاب خلال فترة تلقي العلاج باستخدام أزاسيتيدين اس بي سي. يجب استخدام وسيلة فعالة لمنع الحمل خلال فترة العلاج وبعد العلاج بهذا الدواء لمدة تصل إلى 3 أشهر.</p><p>- تحدث إلى طبيبك إذا كنت ترغب في حفظ الحيوانات المنوية قبل بدء العلاج.</p><p>&nbsp;</p><p><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL">توقف عن القيادة أو&nbsp;استعمال أي أدوات أو&nbsp;آلات إذا شعرت بآثار جانبية مثل الإرهاق.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">سيعطيك الطبيب دواء آخر قبل أزاسيتيدين اس بي سي لمنع الغثيان والقيء.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الجرعة الموصى بها هي 75 ملغم لكل متر مربع من مساحة سطح الجسم. سيحدد طبيبك جرعتك من هذا الدواء وفقًا لحالتك العامة وطولك ووزنك. سيفحص طبيبك تقدم حالتك، وقد يغير جرعتك عند اللزوم.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يتم إعطاء أزاسيتيدين اس بي سي كل يوم لمدة أسبوع، يلي ذلك فترة راحة لمدة 3 أسابيع. يتم تكرار &quot;دورة العلاج&quot; هذه كل 4 أسابيع. ستحصل عادة على 6 دورات علاج على الأقل.</p><p dir="RTL">سيُعطى هذا الدواء لك كحقنة تحت الجلد تحت إشراف طبيب أو&nbsp;ممرض. كما يمكن إعطاؤه تحت الجلد في فخذك أو&nbsp;بطنك أو&nbsp;عضدك.</p><p dir="RTL">إذا كانت لديك أي تساؤلات أخرى بشأن استعمال هذا الدواء؛ استشر الطبيب أو&nbsp;الصيدلي أو&nbsp;الممرض.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">هذا الدواء، مثله مثل جميع الأدوية، يمكن أن يسبب آثارًا جانبية، وإن كانت لا تصيب الجميع.</p><p>&nbsp;</p><p>أخبر طبيبك فورًا إذا شعرت بأي من الآثار الجانبية الآتية:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>النعاس، والارتعاش، واليرقان، وانتفاخ البطن وسهولة التعرض لكدمات</strong>. قد تكون هذه أعراض للفشل الكبدي، ويمكن أن تكون مهددة للحياة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>تورم الساقين والقدمين، وآلام الظهر، وانخفاض معدل التبول، وزيادة معدل العطش، وسرعة النبض، والدوخة والغثيان، والقيء أو&nbsp;انخفاض الشهية والشعور بالارتباك، والتململ أو&nbsp;الإعياء.</strong><strong> </strong>قد تكون هذه أعراض للفشل الكلوي، ويمكن أن تكون مهددة للحياة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>حمى</strong>. قد يحدث ذلك بسبب عدوى نتيجة لانخفاض خلايا الدم البيضاء، وهو ما قد يكون مهددًا للحياة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>ألم في الصدر أو&nbsp;ضيق التنفس، ما قد يكون مصحوبًا بحمى.</strong><strong> </strong>قد يكون ذلك بسبب عدوى بالرئة يُطلق عليها &quot;الالتهاب الرئوي&quot;، ويمكن أن تكون مهددة للحياة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>النزف.</strong><strong> </strong>مثل البراز الدموي بسبب النزف في المعدة أو&nbsp;الأمعاء أو&nbsp;النزف الداخلي بالرأس. قد تكون هذه أعراض انخفاض مستويات الصفائح الدموية في دمك.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>صعوبة في التنفس وتورم الشفاه أو&nbsp;الحكة أو&nbsp;الطفح الجلدي.</strong><strong> </strong>قد يرجع ذلك إلى رد فعل تحسسي (فرط التحسس).</p><p>&nbsp;</p><p>&nbsp;</p><p dir="RTL">تشمل الآثار الجانبية الأخرى:</p><p dir="RTL"><strong>آثارًا جانبية شائعة جدًا</strong><strong> </strong>(قد تصيب أكثر من شخص واحد من كل 10 أشخاص)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض في عدد خلايا الدم الحمراء (فقر الدم) قد تشعر بالإرهاق والشحوب.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض في عدد خلايا الدم البيضاء. قد يكون ذلك مصحوبًا بحمى. كما أنك تكون أكثر عرضة للإصابة بالعدوى.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض عدد الصفائح الدموية (قلة الصفيحات). ستكون أكثر عرضة للنزف والتكدم.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإمساك، الإسهال، الغثيان، القيء.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الالتهاب الرئوي.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في الصدر، ضيق التنفس.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التعب (الإعياء).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاعل في موضع الحقن بما في ذلك الاحمرار أو&nbsp;الألم أو&nbsp;تفاعل جلدي.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان الشهية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; آلام في المفاصل.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كدمات.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; علامات حمراء أو&nbsp;أرجوانية أسفل الجلد.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في البطن (ألم بطني).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحكة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحمى.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الأنف والحلق.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الدوخة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الصداع&rlm;.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشكلات في النوم (أرق).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نزيف في الأنف (الرُعاف).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; آلام العضلات.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الضعف (الوهن).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان الوزن.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض مستويات البوتاسيوم في الدم.</p><p>&nbsp;</p><p dir="RTL"><strong>آثارًا جانبية شائعة </strong>(قد تصيب ما يصل إلى شخص من كل 10 أشخاص):</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النزف الداخلي بالرأس.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدوى بالدم بسبب بكتيريا (الإنتان). قد يرجع ذلك إلى انخفاض مستويات الكريات البيضاء بالدم.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فشل نقي العظم. يمكن أن يسبب ذلك انخفاض مستويات خلايا الدم الحمراء والبيضاء والصفائح الدموية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نوع من فقر الدم، حيث ينخفض عدد خلايا الدم الحمراء والبيضاء والصفائح الدموية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدوى في البول.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدوى فيروسية تسبب قروح البرد (الهربس).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نزف اللثة، نزف في المعدة أو&nbsp;الأمعاء، نزف من الشرج بسبب البواسير (نزف البواسير)، النزف في العينين، النزف أسفل الجلد أو&nbsp;في الجلد (الورم الدموي).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; دم في البول.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قرح بالفم أو&nbsp;اللسان.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغييرات في الجلد في موضع الحقن. يشمل ذلك التورم والانتفاخ الصلب والتكدم والنزف في الجلد (الورم الدموي)، الطفح الجلدي، الحكة، والتغييرات في لون الجلد.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احمرار الجلد.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الالتهابات الجلدية (التهاب النسيج الخلوي).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدوى بالأنف والحلق، أو&nbsp;التهاب الحلق.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احتقان أو&nbsp;سيلان الأنف أو&nbsp;الجيوب الأنفية (التهاب الجيوب الأنفية).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع أو&nbsp;انخفاض ضغط الدم (انخفاض ضغط الدم أو&nbsp;فرط ضغط الدم).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضيق التنفس عند الحركة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الألم في الحلق والحنجرة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عسر الهضم.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الخمول.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور العام بالإعياء.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; القلق.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالارتباك.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تساقط الشعر.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الفشل الكلوي.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الجفاف.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طبقة بيضاء تغطي اللسان والجزء الداخلي من الخد، وأحيانًا بسقف الفم واللثة واللوزتين (العدوى الفطرية الفموية).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإغماء.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض ضغط الدم عند الوقوف (انخفاض ضغط الدم الانتصابي)، ما يسبب الدوخة عند الانتقال إلى وضع وقوف أو&nbsp;جلوس.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النوم، النعاس (النيمومة).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النزيف بسبب أنبوب القسطرة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مرض يؤثر في الأمعاء، ما يمكن أن يسبب الحمى والقيء وألمًا بالمعدة (التهاب الرتج).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سوائل حول الرئتين (انصباب جنبي).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الرعشة (القشعريرة).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تشنجات عضلية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي مثير للحكة على الجلد (الشرى).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تجمع سوائل حول القلب (انصباب تأموري).</p><p>&nbsp;</p><p dir="RTL"><strong>آثارًا جانبية غير شائعة </strong>(قد تصيب ما يصل إلى شخص من كل 100 شخص):</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاعلات تحسسية (فرط الحساسية).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الارتعاش.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الفشل الكبدي.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بقع كبيرة مؤلمة بارزة ذات لون أرغواني على الجلد، ومصحوبة بحمى.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تقرح الجلد المؤلم (تقيح الجلد الغنغريني).</p><p dir="RTL">&middot;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;التهاب بطانة القلب (التهاب التأمور).</p><p>&nbsp;</p><p dir="RTL"><strong>آثارًا جانبية نادرة</strong> (قد تصيب ما يصل إلى شخص من كل 1000 شخص):</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; السعال الجاف.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التورم دون ألم في أطراف الأصابع (التعجر).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; متلازمة انحلال الورم - المضاعفات الأيضية التي يمكن أن تحدث في أثناء علاج السرطان وحتى من دون العلاج أحيانًا. تحدث هذه المضاعفات بسبب نواتج الخلايا السرطانية الميتة وقد تتضمن الآتي: حدوث تغيرات في كيمياء الدم، ارتفاع نسبة البوتاسيوم والفوسفور وحمض اليوريك وانخفاض الكالسيوم، ما يؤدي إلى حدوث تغيرات في وظائف الكلى ومعدل ضربات القلب وحدوث النوبات التشنجية والوفاة أحيانًا.</p><p>&nbsp;</p><p dir="RTL"><strong>غير معروفة (</strong>لا يمكن تقدير معدل التكرار من البيانات المتاحة).</p><p dir="RTL">عدوى في الطبقات العميقة للجلد، والتي تنتشر بسرعة وتسبب تلف الجلد والأنسجة، ويمكن أن تكون مهددة للحياة (التهاب اللفافة النخري).</p><p>&nbsp;</p><p dir="RTL"><strong>الإبلاغ عن الآثار الجانبية</strong><strong> </strong></p><p dir="RTL">إذا تفاقم أي أثر من الآثار الجانبية، أو&nbsp;إذا لاحظت أي أثر جانية غير مذكور في هذه النشرة، فيُرجى إبلاغ الطبيب أو&nbsp;مقدم الرعاية الصحية أو&nbsp;الصيدلي.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يُحفظ الدواء بعيدا عن متناول الأطفال.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تستخدم الدواء بعد مرور تاريخ انتهاء الصلاحية الموضح على شريطة العبوة. يشير تاريخ انتهاء الصلاحية إلى اليوم الأخير في الشهر.</p><p dir="RTL">&nbsp;</p><p dir="RTL">الطبيب أو الصيدلي أو الممرض هم المسئولون عن حفظ وتخزين الدواء. بالإضافة إلى أنهم المسؤولين عن التخلص السليم من الجرعات المتبقية غير المستخدمة من هذا الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL">بالنسبة للعبوة غير المفتوحة لهذا الدواء - لا توجد شروط حفظ وتخزين خاصة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">عند استخدام الدواء في الحال</p><p dir="RTL">&nbsp;</p><p dir="RTL">يجب استخدام الدواء في غضون 45 دقيقة بمجرد إعداد المحلول.</p><p dir="RTL">&nbsp;</p><p dir="RTL">عند استخدام الدواء فيما بعد</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا تم إعداد محلول الدواء باستخدام ماء من أجل الحقن لم يتم تبريده، يجب وضع المحلول في الثلاجة (عند درجة حرارة 2 إلى 8 درجة مئوية) على الفور بعد تجهيزه، ويجب أن يتم حفظه في الثلاجة لمدة لا تزيد عن 8 ساعات.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا تم إعداد محلول الدواء باستخدام ماء من أجل الحقن وقد تم تبريده في الثلاجة (عند درجة حرارة 2 إلى 8 درجة مئوية)، يجب وضع المحلول في الثلاجة (عند درجة حرارة 2 إلى 8 درجة مئوية) على الفور بعد تجهيزه، ويجب أن يتم حفظه في الثلاجة لمدة لا تزيد عن 22 ساعة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يجب ترك المحلول لمدة تصل إلى 30 دقيقة قبل الاستخدام، حتى يصل إلى درجة حرارة الغرفة (20 إلى 25 درجة مئوية).</p><p dir="RTL">&nbsp;</p><p dir="RTL">يجب التخلص من المحلول إذا لوحظ فيه بعض الجسيمات الكبيرة .</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>المادة الفعالة هي</strong> أزاسيتيدين<strong>.</strong></p><p dir="RTL"><strong>المكونات الأخرى</strong> <strong>المستخدمة في التركيبة التصنيعية هي</strong> مانيتول والنيتروجين وماء للحقن.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">قنينة/100 ملغم أزاسيتيدين اس بي سي للحقن عبارة عن مسحوق مجفد بلون أبيض مائل للصفرة في قنينة زجاجية من النوع الأول ذات سدادة مطاطية، وتحتوي القنينة على 100 ملغم من أزاسيتيدين.</p><p dir="RTL">عبوة من قنينة واحدة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>مالك حق التسويق:</strong></p><p dir="RTL">شركة سدير للأدوية (SPC)</p><p dir="RTL">طريق الملك فهد-الرياض جاليري- مبنى A1 &ndash; المملكة العربية السعودية</p><p dir="RTL">هاتف: 0096611920001432</p><p dir="RTL">فاكس: 00966114668195</p><p dir="RTL">إيميل: info@sudairpharma.com</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الشركة المُصَنِعة</strong><strong>:</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">شركة مختبرات دكتور ريدى، ليمتد، وحدة التصنيع السابعة</p><p dir="RTL">&nbsp;</p><p dir="RTL">قطعة أرض من رقم P1 إلى P9، المرحلة الثالثة</p><p dir="RTL">&nbsp;</p><p dir="RTL">دوفادا، فزيز، فيساخاباثنام</p><p dir="RTL">ولاية اندرا براديش، الهند - 046 530</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تاريخ مراجعة النشرة: 10/2021
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Azacitidine SPC for Injection 100mg per vial
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each sterile single use vial contains Azacitidine 100 mg For the full list of excipients see section 6.1
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Powder for concentrate for solution for subcutaneous (SC) injection or intravenous (IV) infusion. White to off white lyophilised powder.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Azacitidine SPC is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (HSCT) with:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; intermediate-2 and high-risk myelodysplastic syndromes (MDS) according to the International Prognostic Scoring System (IPSS),</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; chronic myelomonocytic leukaemia (CMML) with 10-29% marrow blasts without myeloproliferative disorder,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; acute myeloid leukaemia (AML) with 20-30% blasts and multi-lineage dysplasia, according to World Health Organisation (WHO) classification,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; AML with &gt; 30% marrow blasts according to the WHO classification.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Azacitidine SPC treatment should be initiated and monitored under the supervision of a physician experienced in the use of chemotherapeutic agents. Patients should be premedicated with anti-emetics for nausea and vomiting.</p><p><u>Posolo</u>gy</p><p>The recommended starting dose for the first treatment cycle, for all patients regardless of baseline haematology laboratory values, is 75 mg/m2 of body surface area, injected subcutaneously, daily for 7 days, followed by a rest period of 21 days (28-day treatment cycle).</p><p>It is recommended that patients be treated for a minimum of 6 cycles. Treatment should be continued for as long as the patient continues to benefit or until disease progression.</p><p>Patients should be monitored for haematologic response/toxicity and renal toxicities (see section 4.4); a delay in starting the next cycle or a dose reduction as described below may be necessary.</p><p><em><u>Laboratory tests</u></em></p><p>Liver function tests, serum creatinine and serum bicarbonate should be determined prior to initiation of therapy and prior to each treatment cycle. Complete blood counts should be performed prior to initiation of therapy and as needed to monitor response and toxicity, but at a minimum, prior to each treatment cycle.</p><p><em>Dose adjustment due to haematological toxicity</em></p><p>Haematological toxicity is defined as the lowest count reached (nadir) in a given cycle if platelets &le; 50.0 x 109/L and/or absolute neutrophil count (ANC) &le; 1 x 109/L.</p><p>Recovery is defined as an increase of cell line(s) where haematological toxicity was observed of at least half of the absolute difference of nadir and the baseline count plus the nadir count (i.e. blood count at recovery &ge; nadir count + (0.5 x [|baseline count &ndash; nadir count|]).</p><p>Patients without reduced baseline blood counts (i.e. White Blood Cells (WBC) &ge; 3.0 x 109/l and ANC &ge; 1.5 x 109/l, and platelets &ge; 75.0 x 109/l) prior to the first treatment</p><p>If haematological toxicity is observed following Azacitidine SPC treatment, the next cycle of the therapy should be delayed until the platelet count and the ANC have recovered. If recovery is achieved within 14 days, no dose adjustment is necessary.</p><p>&nbsp;</p><p>However, if recovery has not been achieved within 14 days, the dose should be reduced according to the following table. Following dose modifications, the cycle duration should return to 28 days.</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td colspan="2" style="vertical-align:top"><p>Cycle Nadir count</p></td><td rowspan="2" style="vertical-align:top"><p>Dose in the next cycle, if recovery* is not achieved within 14 days (%)</p></td></tr><tr><td style="vertical-align:top"><p>ANC (x 109/L)</p></td><td style="vertical-align:top"><p>Platelets (x 109/L)</p></td></tr><tr><td style="vertical-align:top"><p>&le; 1.0</p></td><td style="vertical-align:top"><p>&le; 50.0</p></td><td style="vertical-align:top"><p>50%</p></td></tr><tr><td style="vertical-align:top"><p>&gt; 1.0</p></td><td style="vertical-align:top"><p>&gt; 50.0</p></td><td style="vertical-align:top"><p>100%</p></td></tr></tbody></table><p>*Recovery = counts &ge; nadir count + (0.5 x [baseline count &ndash; nadir count])</p><p><em>Patients with reduced baseline blood counts (i.e. WBC &lt; 3.0 x 109/L or ANC &lt; 1.5 x 109/L or platelets &lt; 75.0 x 109/L) prior to the first treatment.</em></p><p>Following Azacitidine SPC treatment, if the decrease in WBC or ANC or platelets from that prior to treatment is &le; 50%, or greater than 50% but with an improvement in any cell line differentiation, the next cycle should not be delayed and no dose adjustment made.</p><p>If the decrease in WBC or ANC or platelets is greater than 50% from that prior to treatment, with no improvement in cell line differentiation, the next cycle of Azacitidine SPC therapy should be delayed until the platelet count and the ANC have recovered. If recovery is achieved within 14 days, no dose adjustment is necessary. However, if recovery has not been achieved within 14 days, bone marrow cellularity should be determined. If the bone marrow cellularity is &gt; 50%, no dose adjustments should be made. If bone marrow cellularity is &le; 50%, treatment should be delayed and the dose reduced according to the following table:</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Bone marrow cellularity</p></td><td colspan="2" style="vertical-align:top"><p>Dose in the next cycle if recovery is not achieved within 14 days (%)</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Recovery* &le; 21 days</p></td><td style="vertical-align:top"><p>Recovery* &gt; 21 days</p></td></tr><tr><td style="vertical-align:top"><p>15-50%</p></td><td style="vertical-align:top"><p>100%</p></td><td style="vertical-align:top"><p>50%</p></td></tr><tr><td style="vertical-align:top"><p>&lt; 15%</p></td><td style="vertical-align:top"><p>100%</p></td><td style="vertical-align:top"><p>33%</p></td></tr></tbody></table><p>*Recovery = counts &ge; nadir count + (0.5 x [baseline count &ndash; nadir count]) Following dose modifications, the next cycle duration should return to 28 days.</p><p><em><u>Special populations</u></em><em> Elderly patients</em></p><p>No specific dose adjustments are recommended for the elderly. Because elderly patients are more likely to have decreased renal function, it may be useful to monitor renal function.</p><p>&nbsp;</p><p><em>Patients with renal impairment</em></p><p>Azacitidine can be administered to patients with renal impairment without initial dose adjustment (see section 5.2). If unexplained reductions in serum bicarbonate levels to less than 20 mmol/L occur, the dose should be reduced by 50% on the next cycle. If unexplained elevations in serum creatinine or blood urea nitrogen (BUN) to &ge; 2-fold above baseline values and above upper limit of normal (ULN) occur, the next cycle should be delayed until values return to normal or baseline and the dose should be reduced by 50% on the next treatment cycle (see section 4.4).</p><p>&nbsp;</p><p><em>Patients with hepatic impairment</em></p><p>No formal studies have been conducted in patients with hepatic impairment (see section 4.4). Patients with severe hepatic organ impairment should be carefully monitored for adverse events. No specific modification to the starting dose is recommended for patients with hepatic impairment prior to starting treatment; subsequent dose modifications should be based on haematology laboratory values. Azacitidine SPC is contraindicated in patients with advanced malignant hepatic tumours (see sections 4.3 and 4.4).</p><p><em>Paediatric population</em></p><p>The safety and efficacy of Azacitidine SPC in children aged 0-17 years have not yet been established. Currently available data are described in sections 4.8, 5.1 and 5.2 but no recommendation on a posology can be made.</p><p><u>Method of administration</u></p><p>Reconstituted Azacitidine SPC should be injected subcutaneously into the upper arm, thigh or abdomen. Injection sites should be rotated. New injections should be given at least 2.5 cm from the previous site and never into areas where the site is tender, bruised, red, or hardened.</p><p>&nbsp;</p><p>After reconstitution, the suspension should not be filtered. For instructions on reconstitution of the medicinal product before administration, see section 6.6.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. Advanced malignant hepatic tumours (see section 4.4).
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Haematological toxicity</u></p><p>Treatment with azacitidine is associated with anaemia, neutropenia and thrombocytopenia, particularly during the first 2 cycles (see section 4.8). Complete blood counts should be performed as needed to monitor response and toxicity, but atleast prior to each treatment cycle<em>. </em>After administration of the recommended dose for the first cycle, the dose for subsequent cycles should be reduced or its administration delayed based on nadir counts and haematological response(see section 4.2). Patients should be advised to promptly report febrile episodes. Patients and physicians are also advised to be observant for signs and symptoms of bleeding.</p><p><u>Hepatic impairment</u></p><p>No formal studies have been conducted in patients with hepatic impairment. Patients with extensive tumour burden due to metastatic disease have been reported to experience progressive hepatic coma and death during azacitidine treatment, especially in such patients with baseline serum albumin &lt; 30 g/L. Azacitidine is contraindicated in patients with advanced malignant hepatic tumours (see section 4.3).</p><p><u>Renal impairment</u></p><p>Renal abnormalities ranging from elevated serum creatinine to renal failure and death were reported in patients treated with intravenous azacitidine in combination with other chemotherapeutic agents. In addition, renal tubular acidosis, defined as a fall in serum bicarbonate to &lt; 20 mmol/L in association with an alkaline urine and hypokalaemia (serum potassium &lt; 3 mmol/L) developed in 5 subjects with chronic myelogenous leukaemia (CML) treated with azacitidine and etoposide. If unexplained reductions in serum bicarbonate (&lt; 20 mmol/L) or elevations of serum creatinine or BUN occur, the dose should be reduced or administration delayed (see section 4.2).</p><p>Patients should be advised to report oliguria and anuria to the health care provider immediately.</p><p>Although no clinically relevant differences in the frequency of adverse reactions were noted between subjects with normal renal function compared to those with renal impairment, patients with renal impairment should be closelymonitored for toxicity since azacitidine and/or its metabolites are primarily excreted by the kidney (see section 4.2).</p><p><u>Laboratory tests</u></p><p>Liver function tests, serum creatinine and serum bicarbonate should be determined prior to initiation of therapy and prior to each treatment cycle. Complete blood counts should be performed prior to initiation of therapy and as needed to monitor response and toxicity, but at a minimum, prior to each treatment cycle, see also section 4.8<em>.</em></p><p>&nbsp;</p><p><u>Cardiac and pulmonary disease</u></p><p>Patients with a history of severe congestive heart failure, clinically unstable cardiac disease or pulmonary disease were excluded from the pivotal registration studies (AZA PH GL 2003 CL 001 and AZA-AML-001) and therefore the safety andefficacy of azacitidine in these patients has not been established. Recent data from a clinical study in patients with a known history of cardiovascular or pulmonary disease showed a significantly increased incidence of cardiac events with azacitidine (see section 4.8). It is therefore advised to exercise caution when prescribing azacitidine to these patients. Cardiopulmonary assessment before and during the treatment should be considered.</p><p>&nbsp;</p><p><u>Necrotising fasciitis</u></p><p>Necrotising fasciitis, including fatal cases, have been reported in patients treated with Azacitidine SPC. Azacitidine SPC therapy should be discontinued in patients who develop necrotising fasciitis and appropriate treatment should be promptly initiated.</p><p><u>Tumour lysis syndrome</u></p><p>The patients at risk of tumour lysis syndrome are those with high tumour burden prior to treatment. These patientsshould be monitored closely and appropriate precautions taken.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Based on <em>in vitro </em>data, azacitidine metabolism does not appear to be mediated by cytochrome P450 isoenzymes (CYPs), UDP-glucuronosyltransferases (UGTs), sulfotransferases (SULTs), and glutathione transferases (GSTs); interactions related to these metabolizing enzymes <em>in vivo </em>are therefore considered unlikely.</p><p>Clinically significant inhibitory or inductive effects of azacitidine on cytochrome P450 enzymes are unlikely (see section 5.2).</p><p>No formal clinical drug interaction studies with azacitidine have been conducted.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Women of childbearing potential / Contraception in males and females</u></p><p>Women of childbearing potential and men have to use effective contraception during and up to 3 months after treatment.</p><p><u>Pregnancy</u></p><p>There are no adequate data from the use of azacitidine in pregnant women. Studies in mice have shown reproductive toxicity (see section 5.3). The potential risk for humans is unknown. Based on results from animal studies and its mechanism of action, azacitidine should not be used during pregnancy, especially during the first trimester, unless clearly necessary. The advantages of treatment should be weighed against the possible risk for the foetus in every individual case.</p><p><u>Breast-feeding</u></p><p>It is unknown whether azacitidine/metabolites are excreted in human milk. Due to the potential serious adverse reactions in the nursing child, breast-feeding is contraindicated during azacitidine therapy.</p><p>&nbsp;</p><p><u>Fertility</u></p><p>There are no human data on the effect of azacitidine on fertility. In animals, adverse reactions with azacitidine use on male fertility have been documented (see section 5.3). Men should be advised not to father a child while receiving treatment and must use effective contraception during and up to 3 months after treatment. Before starting treatment, male patients should be advised to seek counselling on sperm storage.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Azacitidine has minor or moderate influence on the ability to drive and use machines. Fatigue has been reported with the use of azacitidine. Therefore, caution is recommended when driving or operating machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Summary of the safety profile</u></p><p>Adult population with MDS, CMML and AML (20-30% marrow blasts)</p><p>Adverse reactions considered to be possibly or probably related to the administration of Azacitidine have occurred in 97% of patients.</p><p>The most common serious adverse reactions noted from the pivotal study (AZA PH GL 2003 CL 001) included febrile neutropenia (8.0%) and anaemia (2.3%), which were also reported in the supporting studies (CALGB 9221 and CALGB 8921). Other serious adverse reactions from these 3 studies included infections such as neutropenic sepsis (0.8%) and pneumonia (2.5%) (some with fatal outcome), thrombocytopenia (3.5%), hypersensitivity reactions (0.25%) and haemorrhagic events (e.g. cerebral haemorrhage [0.5%], gastrointestinal haemorrhage [0.8%] and intracranial haemorrhage [0.5%]).</p><p>The most commonly reported adverse reactions with azacitidine treatment were haematological reactions (71.4%) including thrombocytopenia, neutropenia and leukopenia (usually Grade 3-4), gastrointestinal events (60.6%) including nausea, vomiting (usually Grade 1-2) or injection site reactions (77.1%; usually Grade 1-2).</p><p>Adult population aged 65 years or older with AML with &gt; 30% marrow blasts</p><p>The most common serious adverse reactions (&ge; 10%) noted from AZA-AML-001 within the azacitidine treatment arm included febrile neutropenia (25.0%), pneumonia (20.3%), and pyrexia (10.6%). Other less frequently reported serious adverse reactions in the azacitidine treatment arm included sepsis (5.1%), anaemia (4.2%), neutropenic sepsis (3.0%), urinary tract infection (3.0%), thrombocytopenia (2.5%), neutropenia (2.1%), cellulitis (2.1%), dizziness (2.1%) and dyspnoea (2.1%).</p><p>The most commonly reported (&ge; 30%) adverse reactions with azacitidine treatment were gastrointestinal events, including constipation (41.9%), nausea (39.8%), and diarrhoea (36.9%; usually Grade 1-2), general disorders and administration site conditions including pyrexia (37.7%; usually Grade 1-2) and haematological events, including febrile neutropenia (32.2%) and neutropenia (30.1%; usually Grade 3-4).</p><p>&nbsp;</p><p><u>Tabulated list of adverse reactions</u></p><p>&nbsp;</p><p>Table 1 below contains adverse reactions associated with azacitidine treatment obtained from the main clinical studies in MDS and AML and post marketing surveillance.</p><p>Frequencies are defined as: very common (&ge; 1/10), common (&ge; 1/100 to &lt; 1/10); uncommon (&ge; 1/1,000 to &lt; 1/100); rare (&ge; 1/10,000 to &lt; 1/1,000); very rare (&lt; 1/10,000); not known (cannot be estimated from the available data). Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. Adverse reactions are presented in the table below according to the highest frequency observed in any of the main clinical studies.</p><p>&nbsp;</p><p>Table 1: Adverse reactions reported in patients with MDS or AML treated with azacitidine (clinical studies and post- marketing)</p><p><strong>&nbsp;<img alt="" width="656" height="732" src="data:image/jpeg;base64,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" /></strong></p><p><strong><img alt="" width="642" height="673" src="data:image/jpeg;base64,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" /></strong></p><p>&nbsp;</p><p>&nbsp;</p><p><u>Description of selected adverse reactions</u></p><p><em>Haematologic adverse reactions</em></p><p>The most commonly reported (&ge; 10%) haematological adverse reactions associated with azacitidine treatment include anaemia, thrombocytopenia, neutropenia, febrile neutropenia and leukopenia, and were usually Grade 3 or 4. There is a greater risk of these events occurring during the first 2 cycles, after which they occur with less frequency in patients with restoration of haematological function. Most haematological adverse reactions were managed by routine monitoring of complete blood counts and delaying azacitidine administration in the next cycle, prophylactic antibiotics and/or growth factor support (e.g. G-CSF) for neutropenia and transfusions for anaemia or thrombocytopenia as required.</p><p><em>Infections</em></p><p>Myelosuppression may lead to neutropenia and an increased risk of infection. Serious adverse reactions such as sepsis, including neutropenic sepsis, and pneumonia were reported in patients receiving azacitidine, some with a fatal outcome. Infections may be managed with the use of anti- infectives plus growth factor support (e.g. G-CSF) for neutropenia.</p><p>&nbsp;</p><p>&nbsp;</p><p><em>Bleeding</em></p><p>Bleeding may occur with patients receiving azacitidine. Serious adverse reactions such as gastrointestinal haemorrhage and intracranial haemorrhage have been reported. Patients should be monitored for signs and symptoms of bleeding, particularly those with pre-existing or treatment- related thrombocytopenia.</p><p>&nbsp;</p><p>&nbsp;</p><p><em>Hypersensitivity</em></p><p>Serious hypersensitivity reactions have been reported in patients receiving azacitidine. In case of an anaphylactic-like reaction, treatment with azacitidine should be immediately discontinued and appropriate symptomatic treatment initiated.</p><p>&nbsp;</p><p>&nbsp;</p><p><em>Skin and subcutaneous tissue adverse reactions</em></p><p>The majority of skin and subcutaneous adverse reactions were associated with the injection site. None of these adverse reactions led to discontinuation of azacitidine, or reduction of azacitidine dose in the pivotal studies. The majority of adverse reactions occurred during the first 2 cycles of treatment and tended to decrease with subsequent cycles. Subcutaneous adverse reactions such as injection site rash/inflammation/pruritus, rash, erythema and skin lesion may require management with concomitant medicinal products, such as antihistamines, corticosteroids and non-steroidal anti-inflammatory medicinal products (NSAIDs). These cutaneous reactions have to be distinguished from soft tissue infections, sometimes occurring at injection site. Soft tissue infections, including cellulitis and necrotising fasciitis in rare cases leading to death, have been reported with azacitidine in the post marketing setting. For clinical management of infectious adverse reactions, see section 4.8 Infections.</p><p>&nbsp;</p><p>&nbsp;</p><p><em>Gastrointestinal adverse reactions</em></p><p>The most commonly reported gastrointestinal adverse reactions associated with azacitidine treatment included constipation, diarrhoea, nausea and vomiting. These adverse reactions were managed symptomatically with anti-emetics for nausea and vomiting, anti-diarrhoeals for diarrhoea and laxatives and/or stool softeners for constipation.</p><p>&nbsp;</p><p><em>Renal adverse reactions</em></p><p>Renal abnormalities, ranging from elevated serum creatinine and haematuria to renal tubular acidosis, renal failure and death were reported in patients treated with azacitidine (see section 4.4).</p><p>&nbsp;</p><p>&nbsp;</p><p><em>Hepatic adverse reactions</em></p><p>Patients with extensive tumour burden due to metastatic disease have been reported to experience hepatic failure, progressive hepatic coma and death during azacitidine treatment (see section 4.4).</p><p>&nbsp;</p><p>&nbsp;</p><p><em>Cardiac events</em></p><p>Data from a clinical study allowing enrolment of patients with known history of cardiovascular or pulmonary disease showed an increase in cardiac events in patients with newly diagnosed AML treated with azacitidine (see section 4.4).</p><p>&nbsp;</p><p>&nbsp;</p><p><em>Elderly population</em></p><p>There is limited safety information available with azacitidine in patients &ge; 85 years (with 14 [5.9%] patients &ge; 85 years treated in Study AZA-AML-001).</p><p>&nbsp;</p><p>&nbsp;</p><p><em>Paediatric population</em></p><p>In Study AZA-JMML-001, 28 paediatric patients (1 month to less than 18 years of age) were treated with Azacitidine for MDS (n = 10) or juvenile myelomonocytic leukaemia (JMML) (n = 18) (see section 5.1).</p><p>All 28 patients experienced at least 1 adverse event and 17 (60.7%) experienced at least 1 treatment-related event. The most commonly reported adverse events in the overall paediatric population were pyrexia, haematologic events including anaemia, thrombocytopenia and febrile neutropenia, and gastrointestinal events including constipation and vomiting.</p><p>Three (3) subjects experienced a treatment emergent event leading to drug discontinuation (pyrexia, disease progression and abdominal pain).</p><p>In Study AZA-AML-004, 7 paediatric patients (aged 2 to 12 years) were treated with Azacitidine for AML in molecular relapse after first complete remission [CR1] (see section 5.1).</p><p>All 7 patients experienced at least 1 treatment-related adverse event. The most commonly reported adverse events were neutropenia, nausea, leukopenia, thrombocytopenia, diarrhoea and increased alanine aminotransferase (ALT). Two patients experienced a treatment-related event leading to dose interruption (febrile neutropenia, neutropenia).</p><p>No new safety signals were identified in the limited number of paediatric patients treated with Azacitidine during the course of the clinical study. The overall safety profile was consistent with that of the adult population.</p><p>&nbsp;</p><p><u>To reports any side effect(s):</u></p><p>&nbsp;</p><p><strong>Saudi Arabia:</strong></p><p><!--[if gte vml 1]><o:wrapblock><v:shapetype
  id="_x0000_t202" coordsize="21600,21600" o:spt="202" path="m,l,21600r21600,l21600,xe">
  <v:stroke joinstyle="miter"/>
  <v:path gradientshapeok="t" o:connecttype="rect"/>
 </v:shapetype><v:shape id="Textbox_x0020_1" o:spid="_x0000_s1027" type="#_x0000_t202"
  style='position:absolute;margin-left:87.85pt;margin-top:14.55pt;width:464.3pt;
  height:73.35pt;z-index:-15728640;visibility:visible;mso-wrap-style:square;
  mso-wrap-distance-left:0;mso-wrap-distance-top:0;mso-wrap-distance-right:0;
  mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
  mso-position-horizontal-relative:page;mso-position-vertical:absolute;
  mso-position-vertical-relative:text;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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" filled="f" strokeweight="1.44pt">
  <v:path arrowok="t"/>
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoBodyText style='margin-top:1.0pt;margin-right:0in;margin-bottom:
     0in;margin-left:23.35pt;margin-bottom:.0001pt;text-indent:-.25in;
     mso-list:l4 level1 lfo7;tab-stops:23.35pt'><![if !supportLists]><span
     style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
     Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
     </span></span></span><![endif]><span dir=LTR></span>The<span
     style='letter-spacing:-.2pt'> </span>National<span style='letter-spacing:
     -.1pt'> </span>Pharmacovigilance<span style='letter-spacing:-.15pt'> </span>Centre<span
     style='letter-spacing:-.15pt'> </span><span style='letter-spacing:-.1pt'>(NPC):</span><o:p></o:p></p>
     <p class=MsoBodyText style='margin-top:13.75pt;margin-right:0in;
     margin-bottom:0in;margin-left:23.35pt;margin-bottom:.0001pt;text-indent:
     -.25in;mso-list:l3 level1 lfo6;tab-stops:23.35pt'><![if !supportLists]><span
     style='mso-list:Ignore'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
     </span></span><![endif]><span dir=LTR></span>SFDA<span style='letter-spacing:
     -.2pt'> </span>Call<span style='letter-spacing:-.1pt'> </span>Center:<span
     style='letter-spacing:-.1pt'> </span><span style='letter-spacing:-.2pt'>19999</span><o:p></o:p></p>
     <p class=MsoBodyText style='margin-top:0in;margin-right:0in;margin-bottom:
     0in;margin-left:23.35pt;margin-bottom:.0001pt;text-indent:-.25in;
     mso-list:l3 level1 lfo6;tab-stops:23.35pt'><![if !supportLists]><span
     style='mso-list:Ignore'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
     </span></span><![endif]><span dir=LTR></span>E-mail:<span
     style='letter-spacing:-.15pt'> </span><a href="mailto:npc.drug@sfda.gov.sa"><span
     style='color:#0461C1;letter-spacing:-.1pt'>npc.drug@sfda.gov.sa</span></a><o:p></o:p></p>
     <p class=MsoBodyText style='margin-top:0in;margin-right:0in;margin-bottom:
     0in;margin-left:23.35pt;margin-bottom:.0001pt;text-indent:-.25in;
     mso-list:l3 level1 lfo6;tab-stops:23.35pt'><![if !supportLists]><span
     style='mso-list:Ignore'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
     </span></span><![endif]><span dir=LTR></span>Website:<span
     style='letter-spacing:-.15pt'> </span><u style='text-underline:#0461C1'><span
     style='color:#0461C1;letter-spacing:-.1pt'>https://ade.sfda.gov.sa/</span></u><o:p></o:p></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
  <w:wrap type="topAndBottom" anchorx="page"/>
 </v:shape><![endif]--></p><table cellpadding="0" cellspacing="0" align="left"><tbody><tr><td>&nbsp;</td></tr><tr><td>&nbsp;</td><td>&nbsp;</td></tr></tbody></table><p><!--[if gte vml 1]></o:wrapblock><![endif]--></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The National Pharmacovigilance Centre (NPC):</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SFDA Call Center: 19999</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: <u>https://ade.sfda.gov.sa/</u></p><p><strong>&nbsp;</strong></p><p><strong>Other GCC States:</strong></p><p><!--[if gte vml 1]><o:wrapblock><v:shape
  id="Textbox_x0020_2" o:spid="_x0000_s1026" type="#_x0000_t202" style='position:absolute;
  margin-left:87.85pt;margin-top:14.65pt;width:464.3pt;height:17.05pt;
  z-index:-15728128;visibility:visible;mso-wrap-style:square;
  mso-wrap-distance-left:0;mso-wrap-distance-top:0;mso-wrap-distance-right:0;
  mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
  mso-position-horizontal-relative:page;mso-position-vertical:absolute;
  mso-position-vertical-relative:text;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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" filled="f" strokeweight="1.44pt">
  <v:path arrowok="t"/>
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoBodyText style='margin-top:.9pt;margin-right:0in;margin-bottom:
     0in;margin-left:5.35pt;margin-bottom:.0001pt;tab-stops:23.35pt'><span
     style='letter-spacing:-.5pt'>-</span><span style='mso-tab-count:1'>     </span>Please<span
     style='letter-spacing:-.15pt'> </span>contact<span style='letter-spacing:
     -.1pt'> </span>the<span style='letter-spacing:-.05pt'> </span>relevant<span
     style='letter-spacing:-.1pt'> </span>competent<span style='letter-spacing:
     -.05pt'> </span><span style='letter-spacing:-.1pt'>authority.</span><o:p></o:p></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
  <w:wrap type="topAndBottom" anchorx="page"/>
 </v:shape><![endif]--></p><table cellpadding="0" cellspacing="0" align="left"><tbody><tr><td>&nbsp;</td></tr><tr><td>&nbsp;</td><td>&nbsp;</td></tr></tbody></table><p><!--[if gte vml 1]></o:wrapblock><![endif]-->-&nbsp;&nbsp;&nbsp;&nbsp; Please contact the relevant competent authority.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>One case of overdose with azacitidine was reported during clinical studies. A patient experienced diarrhoea, nausea, and vomiting after receiving a single intravenous dose of approximately 290 mg/m2, almost 4 times the recommended starting dose.</p><p>In the event of overdose, the patient should be monitored with appropriate blood counts and should receive supportive treatment, as necessary. There is no known specific antidote for azacitidine overdose.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Antineoplastic agents, pyrimidine analogues; ATC code: L01BC07 <u>Mechanism of action</u></p><p>Azacitidine is believed to exert its antineoplastic effects by multiple mechanisms including cytotoxicity on abnormal haematopoietic cells in the bone marrow and hypomethylation of DNA. The cytotoxic effects of azacitidine may result from multiple mechanisms, including inhibition of DNA, RNA and protein synthesis, incorporation into RNA and DNA, andactivation of DNA damage pathways. Non-proliferating cells are relatively insensitive to azacitidine. Incorporation of azacitidine into DNA results in the inactivation of DNA methyltransferases, leading to hypomethylation of DNA. DNA hypomethylation of aberrantly methylated genes involved in normal cell cycle regulation, differentiation and death pathways may result in gene re-expression and restoration of cancer-suppressing functions to cancer cells. The relative importance of DNA hypomethylation versus cytotoxicity or other activities of azacitidine to clinical outcomes has not been established.</p><p><u>Clinical efficacy and safety</u></p><p><em>Adult population (MDS, CMML and AML [20-30% marrow blasts])</em></p><p>The efficacy and safety of Azacitidine SPC were studied in an international, multicentre, controlled, open- label, randomised, parallel-group, Phase 3 comparative study (AZA PH GL 2003 CL 001) in adult patients with: intermediate-2 and high-riskMDS according to the International Prognostic Scoring System (IPSS), refractory anaemia with excess blasts (RAEB),refractory anaemia with excess blasts in transformation (RAEB-T) and modified chronic myelomonocytic leukaemia (mCMML) according to the French American British (FAB) classification system. RAEB-T patients (21-30% blasts) are now considered to be AML patients under the current WHO classification system. Azacitidine plus best supportive care (BSC) (n = 179) was compared to conventional care regimens (CCR). CCR consisted of BSC alone (n = 105), low-dose cytarabine plus BSC (n = 49) or standard induction chemotherapy plus BSC (n = 25). Patients were pre- selected by theirphysician to 1 of the 3 CCR prior to randomisation. Patients received this pre-selected regimen if not randomised to Azacitidine SPC. As part of the inclusion criteria, patients were required to have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2. Patients with secondary MDS were excluded from the study. The primary endpoint of the study was overall survival. Azacitidine SPC was administered at a subcutaneous dose of 75 mg/m2 daily for 7 days, followed by a rest period of 21 days (28-day treatment cycle) for a median of 9 cycles (range = 1-39) and a mean of 10.2 cycles. Withinthe Intent to Treat population (ITT), the median age was 69 years (range 38 to 88 years).</p><p>In the ITT analysis of 358 patients (179 azacitidine and 179 CCR), Azacitidine SPC treatment was associated with a median survival of 24.46 months versus 15.02 months for those receiving CCR treatment, a difference of 9.4 months, with a stratified log-rank p-value of 0.0001. The hazard ratio (HR) for the treatment effect was 0.58 (95% CI: 0.43, 0.77). Thetwo-year survival rates were 50.8% in patients receiving azacitidine <em>versus </em>26.2% in patients receiving CCR (p &lt; 0.0001).</p><p>&nbsp;</p><p><img alt="" width="922" height="542" src="data:image/jpeg;base64,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" /></p><p>KEY: AZA = azacitidine; CCR = conventional care regimens; CI = confidence interval; HR = hazard ratio</p><p>The survival benefits of Azacitidine SPC were consistent regardless of the CCR treatment option (BSC alone, low-dose cytarabineplus BSC or standard induction chemotherapy plus BSC) utilised in the control arm.</p><p>When IPSS cytogenetic subgroups were analysed, similar findings in terms of median overall survival were observed inall groups (good, intermediate, poor cytogenetics, including monosomy 7).</p><p>On analyses of age subgroups, an increase in median overall survival was observed for all groups (&lt; 65 years, &ge; 65years and &ge; 75 years).</p><p>Azacitidine SPC treatment was associated with a median time to death or transformation to AML of</p><p>13.0 months versus 7.6 months for those receiving CCR treatment, an improvement of 5.4 months with a stratified log-rank p-value of 0.0025.</p><p>Azacitidine SPC treatment was also associated with a reduction in cytopenias, and their related symptoms. Azacitidine SPC treatment ledto a reduced need for red blood cell (RBC) and platelet transfusions. Of the patients in the azacitidine group who were RBC transfusion dependent at baseline, 45.0% of these patients became RBC transfusion independent during the treatment period, compared with 11.4% of the patients in the combined CCR groups (a statistically significant (p &lt; 0.0001) difference of 33.6% (95% CI: 22.4, 44.6). In patients who were RBC transfusion dependent at baseline and became independent, the median duration of RBC transfusion independence was 13 months in the azacitidine group.</p><p>Response was assessed by the investigator or by the Independent Review Committee (IRC). Overall response (complete remission [CR] + partial remission [PR]) as determined by the investigator was 29% in the azacitidine group and 12% in the combined CCR group (p = 0.0001). Overall response (CR + PR) as determined by the IRC in AZA PH GL 2003 CL 001 was 7% (12/179) in the azacitidine group compared with 1% (2/179) in the combined CCR group (p = 0.0113). The differences between the IRC and investigator assessments of response were a consequence of the International Working Group (IWG) criteria requiring improvement in peripheral blood counts and maintenance of these improvements for a minimum of 56 days. A survival benefit was also demonstrated in patients that had not achieved a complete/partial response following azacitidine treatment. Haematological improvement (major or minor) as determinedby the IRC was achieved in 49% of patients receiving azacitidine compared with 29% of</p><p>&nbsp;</p><p>patients treated with combinedCCR (p &lt; 0.0001).</p><p>In patients with one or more cytogenetic abnormalities at baseline, the percentage of patients with a major cytogenetic response was similar in the azacitidine and combined CCR groups. Minor cytogenetic response was statistically significantly (p = 0.0015) higher in the azacitidine group (34%) compared with the combined CCR group (10%).</p><p><em>Adult population aged 65 years or older with AML with &gt; 30% marrow blasts</em></p><p>The results presented below represent the intent-to-treat population studied in AZA-AML-001 (see section 4.1 for theapproved indication).</p><p>&nbsp;</p><p>The efficacy and safety of Azacitidine SPC was studied in an international, multicentre, controlled, open- label, parallel group Phase 3 study in patients 65 years and older with newly diagnosed de novo or secondary AML with &gt; 30% bone marrowblasts according to the WHO classification, who were not eligible for HSCT. Azacitidine SPC plus BSC (n = 241) was compared toCCR. CCR consisted of BSC alone (n = 45), low- dose cytarabine plus BSC (n = 158), or standard intensive chemotherapy with cytarabine and anthracycline plus BSC (n = 44). Patients were pre-selected by their physician to 1 ofthe 3 CCRs prior to randomization. Patients received the pre-selected regimen if not randomised to Azacitidine SPC. As part ofthe inclusion criteria, patients were required to have an ECOG performance status of 0-2 and intermediate- or poor-risk cytogenetic abnormalities. The primary endpoint of the study was overall survival.</p><p>Azacitidine SPC was administered at a SC dose of 75mg/m2/day for 7 days, followed by a rest period of 21 days (28 day treatment cycle), for a median of 6 cycles (range: 1 to 28), BSC-only patients for a median of 3 cycles (range: 1 to 20),low-dose cytarabine patients for a median of 4 cycles (range 1 to 25) and standard intensive chemotherapy patients for a median of 2 cycles (range: 1 to 3, induction cycle plus 1 or 2 consolidation cycles).</p><p>The individual baseline parameters were comparable between the Azacitidine SPC and CCR groups. The median age of the subjects was 75.0 years (range: 64 to 91 years), 75.2% were Caucasian and 59.0% were male. At baseline 60.7% were classified as AML not otherwise specified, 32.4% AML with myelodysplasia-related changes, 4.1% therapy-related myeloid neoplasms and 2.9% AML with recurrent genetic abnormalities according to the WHO classification.</p><p>In the ITT analysis of 488 patients (241 Azacitidine SPC and 247 CCR), Azacitidine SPC treatment was associated with a median survivalof 10.4 months versus 6.5 months for those receiving CCR treatment, a difference of 3.8 months, with a stratified log- rank p-value of 0.1009 (two-sided). The hazard ratio for the treatment effect was 0.85 (95% CI = 0.69, 1.03). The one- year survival rates were 46.5% in patients receiving Azacitidine SPC versus 34.3% in patients receiving CCR.</p><p>&nbsp;</p><p><img alt="" width="846" height="447" src="data:image/jpeg;base64,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" /></p><p>&nbsp;</p><p>The Cox PH model adjusted for pre-specified baseline prognostic factors defined a HR for Azacitidine SPC versus CCR of 0.80(95% CI = 0.66, 0.99; p = 0.0355).</p><p>In addition, although the study was not powered to demonstrate a statistically significant difference when comparing azacitidine to the preselection CCR treatment groups, the survival of Azacitidine SPC treated patients was longer when comparedto CCR treatment options BSC alone, low-dose cytarabine plus BSC and were similar when compared to standard intensive chemotherapy plus BSC.</p><p>&nbsp;</p><p>In all pre-specified subgroups (age [&lt; 75 years and &ge; 75 years], gender, race, ECOG performance status [0 or 1 and 2] , baseline cytogenetic risk [intermediate and poor], geographic region, WHO classification of AML [including AML with myelodysplasia-related changes], baseline WBC count [&le; 5 x109/L and &gt; 5 x 109/L], baseline bone marrow blasts [&le; 50%and &gt; 50%] and prior history of MDS), there was a trend in OS benefit in favour of Azacitidine SPC. In a few pre-specified subgroups, the OS HR reached statistical significance including patients with poor cytogenetic risk, patients with AML with myelodysplasia-related changes, patients &lt; 75 years, female patients and white patients.</p><p>Haematologic and cytogenetic responses were assessed by the investigator and by the IRC with similar results. Overallresponse rate (complete remission [CR] + complete remission with incomplete blood count recovery [CRi]) as determined by the IRC was 27.8% in the Azacitidine SPC group and 25.1% in the combined CCR group (p = 0.5384). In patientswho achieved CR or CRi, the median duration of remission was 10.4 months (95% CI = 7.2, 15.2) for the Azacitidine SPC subjects and 12.3 months (95% CI = 9.0, 17.0) for the CCR subjects. A survival benefit was also demonstrated inpatients that had not achieved a complete response for Azacitidine SPC compared to CCR.</p><p>Azacitidine SPC treatment improved peripheral blood counts and led to a reduced need for RBC and platelet transfusions. A patient was considered RBC or platelet transfusion dependent at baseline if the subject had one or more RBC or platelet transfusions during the 56 days (8 weeks) on or prior to randomization, respectively. A patient was considered RBC orplatelet transfusion independent during the treatment period if the subject had no RBC or platelet transfusions during anyconsecutive 56 days during the reporting period, respectively.</p><p>Of the patients in the Azacitidine SPC group who were RBC transfusion dependent at baseline, 38.5% (95% CI = 31.1, 46.2) ofthese patients became RBC transfusion independent during the treatment period, compared with 27.6% of (95% CI = 20.9, 35.1) patients in the combined CCR groups. In patients who were RBC transfusion dependent at baseline and achieved transfusion independence on treatment, the median duration of RBC transfusion independence was 13.9months in the Azacitidine SPC group and was not reached in the CCR group.</p><p>Of the patients in the Azacitidine SPC group who were platelet transfusion dependent at baseline, 40.6% (95% CI = 30.9, 50.8) ofthese patients became platelet transfusion independent during the treatment period, compared with 29.3% of (95% CI = 19.7, 40.4) patients in the combined CCR groups. In patients who were platelet transfusion dependent at baseline and achieved transfusion independence on treatment, the median duration of platelet transfusion independence was 10.8months in the Azacitidine SPC group and 19.2 months in the CCR group.</p><p>Health- Related Quality of Life (HRQoL) was assessed using the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30). HRQoL data could be analysed for a subset of the full study population. While there are limitations in the analysis, the available data suggest that patients do not experience meaningful deterioration in quality of life during treatment with Azacitidine SPC.</p><p>&nbsp;</p><p><em>Paediatric population</em></p><p>Study AZA-JMML-001 was a Phase 2, international, multicentre, open-label study to evaluate the pharmacokinetics, pharmacodynamics, safety and activity of Azacitidine SPC prior to HSCT in paediatric patients with newly diagnosed advanced MDS or JMML. The primary objective of the clinical study was to evaluate the effect of Azacitidine SPC on response rate at Cycle3, Day 28.</p><p>Patients (MDS, n = 10; JMML, n = 18, 3 months to 15 years; 71% male) were treated with intravenous Azacitidine SPC 75 mg/m2, daily on Days 1 to 7 of a 28-day cycle for a minimum of 3 cycles and a maximum of 6 cycles.</p><p>Enrolment in the MDS study arm was stopped after 10 MDS patients due to a lack of efficacy: no confirmed responseswere recorded in these 10 patients.</p><p>In the JMML study arm, 18 patients (13 <em>PTPN11</em>, 3 <em>NRAS</em>, 1 <em>KRAS </em>somatic mutations and 1 clinical diagnosis of neurofibromatosis type 1 [<em>NF-1]</em>) were enrolled. Sixteen patients completed 3 cycles of therapy and 5 of them completed6 cycles. A total of 11 JMML patients had a clinical response at Cycle 3, Day 28, of these 11 subjects, 9 (50%) subjects had a confirmed clinical response (3 subjects with cCR and 6 subjects with cPR). Among the cohort of JMML patientstreated with Azacitidine SPC, 7 (43.8%) patients had a sustained platelet response (counts &ge; 100 &times; 109/L) and 7 (43.8%) patientsrequired transfusions at HSCT. 17 of 18 patients proceeded to HSCT.</p><p>Because of the study design (small patient numbers and various confounding factors), it cannot be concluded from this clinical study whether Azacitidine SPC prior to HSCT improves survival outcome in JMML patients.</p><p>&nbsp;</p><p>Study AZA-AML-004 was a Phase 2, multicentre, open-label study to evaluate the safety, pharmacodynamics and efficacy of Azacitidine SPC compared to no anti-cancer treatment in children and young adults with AML in molecular relapse afterCR1.</p><p>Seven patients (median age 6.7 years [range 2 to 12 years]; 71.4% male) were treated with intravenous Azacitidine SPC 100mg/m2, daily on Days 1 to 7 of each 28-day cycle for a maximum of 3 cycles.</p><p>Five patients had minimal residual disease (MRD) assessment at Day 84 with 4 patients achieving either molecular stabilization (n = 3) or molecular improvement (n = 1) and 1 patient had clinical relapse. Six of 7 patients (90% [95% CI =0.4, 1.0]) treated with azacitidine underwent HSCT.</p><p>Due to the small sample size, the efficacy of Azacitidine SPC in paediatric AML cannot be established.See section 4.8 for safety information.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Absorption</u></p><p>Following subcutaneous administration of a single 75 mg/m2 dose, azacitidine was rapidly absorbed with peak plasma concentrations of 750 &plusmn; 403 ng/mL occurring at 0.5 h after dosing (the first sampling point). The absolute bioavailability of azacitidine after subcutaneous relative to intravenous administration (single 75 mg/m2 doses) was approximately 89%based on the area under the curve (AUC).</p><p>Area under the curve and maximum plasma concentration (C<sub>max</sub>) of subcutaneous admiminstration of azacitidine wereapproximately proportional within the 25 to 100 mg/m2 dose range.</p><p><u>Distribution</u></p><p>Following intravenous administration, the mean volume of distribution was 76 &plusmn; 26 L, and systemic clearance was 147 &plusmn;47 L/h.</p><p><u>Biotransformation</u></p><p>Based on <em>in vitro </em>data, azacitidine metabolism does not appear to be mediated by cytochrome P450 isoenzymes (CYPs), UDP-glucuronosyltransferases (UGTs), sulfotransferases (SULTs), and glutathione transferases (GSTs).</p><p>Azacitidine undergoes spontaneous hydrolysis and deamination mediated by cytidine deaminase. In human liver S9 fractions, formation of metabolites was independent of NADPH implying that azacitidine metabolism was not mediated by cytochrome P450 isoenzymes. An <em>in vitro </em>study of azacitidine with cultured human hepatocytes indicates that at concentrations of 1.0 &micro;M to 100 &micro;M (i.e. up to approximately 30-fold higher than clinically achievable concentrations), azacitidine does not induce CYP 1A2, 2C19, or 3A4 or 3A5. In studies to assess inhibition of a series of P450 isoenzymes (CYP 1A2, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1 and 3A4) azacitidine up to 100 &mu;M did not produce inhibition.Therefore, CYP enzyme induction or inhibition by azacitidine at clinically achievable plasma concentrations is unlikely.</p><p><u>Elimination</u></p><p>Azacitidine is cleared rapidly from plasma with a mean elimination half-life (t<sub>&frac12;</sub>) after subcutaneous administration of 41 &plusmn;8 minutes. No accumulation occurs after subcutaneous administration of 75 mg/m2 azacitidine once daily for 7 days.</p><p>Urinary excretion is the primary route of elimination of azacitidine and/or its metabolites. Following intravenous and subcutaneous administration of 14C-azacitidine, 85 and 50% of the administered radioactivity was recovered in urinerespectively, while &lt; 1% was recovered in faeces.</p><p><u>Special populations</u></p><p>The effects of hepatic impairment (see section 4.2), gender, age, or race on the pharmacokinetics of azacitidine have not been&nbsp;formally&nbsp;studied.</p><p>&nbsp;</p><p><em>Paediatric population</em></p><p>In Study AZA-JMML-001, pharmacokinetic analysis was determined from 10 MDS and 18 JMML paediatric patients on Day 7 of Cycle 1 (see section 5.1). The median age (range) of the MDS patients was 13.3 (1.9- 15) years and 2.1 (0.2-6.9) years for JMML patients.</p><p>Following intravenous administration of a 75 mg/m2 dose, Azacitidine SPC rapidly reached C<sub>max</sub> within 0.083 hours in both MDS and JMML populations. The geometric mean C<sub>max</sub> were 1797.5 and 1066.3 ng/mL, and the geometric mean AUC<sub>0-&infin;</sub>were 606.9 and 240.2 ng∙h/mL, for MDS and JMML patients, respectively. The geometric mean volume of distribution inMDS and JMML subjects were 103.9 and 61.1 L, respectively. It appeared that the total plasma exposure of Azacitidine SPC was higher in MDS subjects; however, moderate to high between-patient variability was noted for both AUC and C<sub>max</sub>.</p><p>The geometric mean t<sub>&frac12;</sub> were 0.4 and 0.3 hours, and the geometric mean clearances were 166.4 and 148.3 L/h for MDSand JMML, respectively.</p><p>Pharmacokinetic data from Study AZA-JMML-001 were pooled together and compared to pharmacokinetic data from 6adult subjects with MDS administered 75 mg/m2 Azacitidine SPC intravenously in Study AZA-2002-BA-002. Mean C<sub>max</sub> and AUC<sub>0-t</sub> of Azacitidine SPC were similar between adult patients and paediatric patients after intravenous administration (2750 ng/mL versus 2841 ng/mL and 1025 ng∙h/mL versus 882.1 ng∙h/mL, respectively).</p><p>In Study AZA-AML-004, pharmacokinetic analysis was determined from 6 of the 7 paediatric patients, which had at leastone measurable postdose pharmacokinetic concentration (see section 5.1). The median age (range) of the AML patients was 6.7 (2-12) years.</p><p>Following multiple doses of 100 mg/m2, the geometric means for C<sub>max</sub> and AUC<sub>0-tau</sub> on Cycle 1 Day 7 were 1557 ng/mLand 899.6 ng∙h/mL, respectively, with high inter-subject variability (CV% of 201.6% and 87.8%, respectively) observed. Azacitidine rapidly reached C<sub>max</sub>, with a median time of 0.090 hours post-intravenous administration and declined with ageometric mean t<sub>1/2</sub> of 0.380 hours. The geometric means for clearance and volume of distribution were 127.2 L/h and 70.2 L, respectively.</p><p>Pharmacokinetic (azacitidine) exposure observed in children with AML at molecular relapse after CR1 was comparableto exposure from pooled data of 10 children with MDS and 18 children with JMML and also comparable to azacitidine exposure in adults with MDS.</p><p>&nbsp;</p><p><u>Renal impairment</u></p><p>Renal impairment has no major effect on the pharmacokinetic exposure of azacitidine after single and multiple subcutaneous administrations. Following subcutaneous administration of a single 75 mg/m2 dose, mean exposure values (AUC and C<sub>max</sub>) from subjects with mild, moderate and severe renal impairment were increased by 11-21%, 15- 27%, and 41-66%, respectively, compared to normal renal function subjects. However, exposure was within the samegeneral range of exposures observed for subjects with normal renal function. Azacitidine can be administered to patientswith renal impairment without initial dose adjustment provided these patients are monitored for toxicity since azacitidine and/or its metabolites are primarily excreted by the kidney.</p><p><u>Pharmacogenomics</u></p><p>The effect of known cytidine deaminase polymorphisms on azacitidine metabolism has not been formally investigated.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Azacitidine induces both gene mutations and chromosomal aberrations in bacterial and mammalian cell systems in vitro. The potential carcinogenicity of azacitidine was evaluated in mice and rats. Azacitidine induced tumours of the haematopoietic system in female mice, when administered intraperitoneally 3 times per week for 52 weeks. An increased incidence of tumours in the lymphoreticular system, lung, mammary gland, and skin was seen in mice treated with azacitidine administered intraperitoneally for 50 weeks. A tumorigenicity study in rats revealed an increased incidence of testicular tumours.</p><p>Early embryotoxicity studies in mice revealed a 44% frequency of intrauterine embryonal death (increased resorption) after a single intraperitoneal injection of azacitidine during organogenesis. Developmental abnormalities in the brain have been detected in mice given azacitidine on or before closure of the hard palate. In rats, azacitidine caused no adverse reactions when given pre- implantation, but it was clearly embryotoxic when given during organogenesis. Foetal abnormalities during organogenesis in rats included: CNS anomalies (exencephaly/encephalocele), limb anomalies (micromelia, club foot, syndactyly, oligodactyly) and others (microphthalmia, micrognathia, gastroschisis, oedema, and rib abnormalities).</p><p>Administration of azacitidine to male mice prior to mating with untreated female mice resulted in decreased fertility and loss of offspring during subsequent embryonic and postnatal development. Treatment of male rats resulted in decreased weight of the testes and epididymides, decreased sperm counts, decreased pregnancy rates, an increase in abnormal embryos and increased loss of embryos in mated females (see section 4.4).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Mannitol</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Azacitidine SPC for injection is incompatible with 5% Dextrose solutions, Hespan, or solutions that contain bicarbonate. These solutions have the potential to increase the rate of degradation of azacitidine for injection and should therefore be avoided.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Unopened Vial: 36 months
Reconstituted Suspension can be store up to:
•	1 hour at 25ºC, or
•	8 hours between 2ºC and 8ºC, or
•	22 hours between 2ºC and 8ºC when reconstituted with refrigerated (2ºC-8ºC) water for injections.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Type I glass vial with rubber stopper containing 100 mg of Azacitidine. Pack of 1 vial.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Recommendations for safe handlin</u>g</p><p>Azacitidine SPC is a cytotoxic medicinal product and, as with other potentially toxic compounds, caution should be exercised when handling and preparing azacitidine suspensions. Procedures for proper handling and disposal of anticancer medicinal products should be applied.</p><p>If reconstituted azacitidine comes into contact with the skin, immediately and thoroughly wash with soap and water. If it comes into contact with mucous membranes, flush thoroughly with water.</p><p><u>Reconstitution procedure</u></p><p>Azacitidine SPC should be reconstituted with water for injections. The shelf life of the reconstituted medicinal product can be extended by reconstituting with refrigerated (2 &deg;C to 8 &deg;C) water for injections. Details on storage of the reconstituted product are provided below.</p><p>1.&nbsp;&nbsp; The following supplies should be assembled:</p><p>Vial (s) of azacitidine; vial(s) of water for injections; non-sterile surgical gloves; alcohol wipes; 5 mL injection syringe(s) with needle(s).</p><p>2.&nbsp;&nbsp; 4 mL of water for injections should be drawn into the syringe, making sure to purge any air trapped within the syringe.</p><p>3.&nbsp;&nbsp; The needle of the syringe containing the 4 mL of water for injections should be inserted through the rubber top of the azacitidine vial followed by injection of the water for injections into the vial.</p><p>4.&nbsp;&nbsp; Following removal of the syringe and needle, the vial should be vigorously shaken until a uniform cloudy suspension is achieved. After reconstitution each mL of suspension will contain 25 mg of azacitidine (100 mg/4 mL). The reconstituted product is a homogeneous, cloudy suspension, free of agglomerates. <u>The product should be discarded if it contains</u> <u>large particles or agglomerates. Do not</u> <u>filter the suspension after reconstitution since this could remove the active</u> <u>substance. It must be taken</u> <u>into account that filters are present in some adaptors, spikes and closed systems; therefore such systems</u> <u>should not be used for administration of the medicinal product after reconstitution<em>.</em></u></p><p>5.&nbsp;&nbsp; The rubber top should be cleaned and a new syringe with needle inserted into the vial. The vial should then be turned upside down, making sure the needle tip is below the level of the liquid. The plunger should then be pulled back to withdraw the amount of medicinal product required for the proper dose, making sure to purge any air trapped within the syringe. The syringe with needle should then be removed from the vial and the needle disposed of.</p><p>6.&nbsp;&nbsp; A fresh subcutaneous needle (recommended 25-gauge) should then be firmly attached to the syringe. The needle should not be purged prior to injection, in order to reduce the incidence of local injection site reactions.</p><p>7.&nbsp;&nbsp; When more than 1 vial is needed all the above steps for preparation of the suspension should be repeated. For doses requiring more than 1 vial, the dose should be equally divided e.g., dose 150 mg = 6 mL, 2 syringes with 3 mL in each syringe. Due to retention in the vial and needle, it may not be feasible to withdraw all of the suspension from the vial.</p><p>8.&nbsp;&nbsp; The contents of the dosing syringe must be re-suspended immediately prior to administration. The syringe filled with reconstituted suspension should be allowed up to 30 minutes prior to administration to reach a temperature of approximately 20 &deg;C-25 &deg;C. If the elapsed time is longer than 30 minutes, the suspension should be discarded appropriately and a new dose prepared. To re-suspend, vigorously roll the syringe between the palms until a uniform, cloudy suspension is achieved. <u>The product should be</u> <u>discarded if it contains large particles or agglomerates</u>.</p><p><u>Storage of the reconstituted product</u></p><p>For storage conditions after reconstitution of the medicinal product, see section 6.3. <u>Calculation of an</u> <u>individual dose</u></p><p>The total dose, according to the body surface area (BSA) can be calculated as follows: Total dose (mg) = Dose (mg/m2) x BSA (m2)</p><p>&nbsp;</p><p>The following table is provided only as an example of how to calculate individual azacitidine doses based on an average BSA value of 1.8 m2.</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><u>Dose mg/m2</u></p><p><em><u>(%</u></em><em><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; recommended</u></em><em> </em><em><u>starting dose</u></em><em>)</em></p></td><td style="vertical-align:top"><p><u>Total dose based on BSA</u> <u>value of 1.8 m2</u></p></td><td style="vertical-align:top"><p><u>Number of vials required</u></p></td><td style="vertical-align:top"><p><u>Total volume of</u> <u>reconstituted</u> <u>suspension</u> <u>required</u></p></td></tr><tr><td style="vertical-align:top"><p>75 mg/m2 (100%)</p></td><td style="vertical-align:top"><p>135 mg</p></td><td style="vertical-align:top"><p>2 vials</p></td><td style="vertical-align:top"><p>5.4 mL</p></td></tr><tr><td style="vertical-align:top"><p>37.5 mg/m2 (50%)</p></td><td style="vertical-align:top"><p>67.5 mg</p></td><td style="vertical-align:top"><p>1 vial</p></td><td style="vertical-align:top"><p>2.7 mL</p></td></tr><tr><td style="vertical-align:top"><p>25 mg/m2 (33%)</p></td><td style="vertical-align:top"><p>45 mg</p></td><td style="vertical-align:top"><p>1 vial</p></td><td style="vertical-align:top"><p>1.8 mL</p></td></tr></tbody></table><p><u>Method of administration</u></p><p>Reconstituted Azacitidine SPC should be injected subcutaneously (insert the needle at a 45-90&deg; angle) using a 25-gauge needle into the upper arm, thigh or abdomen.</p><p>Doses greater than 4 mL should be injected into two separate sites.</p><p>Injection sites should be rotated. New injections should be given at least 2.5 cm from the previous site and never into areas where the site is tender, bruised, red, or hardened.</p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Sudair Pharma Company (SPC)
King Fahad Road, Riyadh Gallery - Building A1, Riyadh, Saudi Arabia Tel: +966-11-920001432
Fax: +966-11-4668195
Email: info@sudairpharma.com
Mailing: P.O. Box 12363 Riyadh, Saudi Arabia


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                10/2021
 
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>